Man who Picked Bitcoin at $428 Says "Buy Genesis"
He Picked Bitcoin (And Dogecoin) in 2016. What He's Recommending Now Could Turn Heads...

NYSE:BMY - Bristol-Myers Squibb Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $72.85
  • Forecasted Upside: 11.62 %
  • Number of Analysts: 14
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 10 Buy Ratings
  • 1 Strong Buy Ratings
$65.26
▼ -0.68 (-1.03%)

This chart shows the closing price for BMY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Bristol-Myers Squibb Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BMY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BMY

Analyst Price Target is $72.85
▲ +11.62% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. The average price target is $72.85, with a high forecast of $78.00 and a low forecast of $62.00. The average price target represents a 11.62% upside from the last price of $65.26.

This chart shows the closing price for BMY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
This Is By Far My #1 Income Stock
This company owns the bestselling drug in the world, which brought in $19.9 billion in revenue last year. And today, I want to give you the name, the ticker symbol and my full analysis completely free - no strings attached.
pixel

Current Consensus is Buy

The current consensus among 14 contributing investment analysts is to buy stock in Bristol-Myers Squibb. This rating has held steady since January 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 1 strong buy ratings
  • 9 buy ratings
  • 15 hold ratings
  • 0 sell ratings
12/31/2019
  • 1 strong buy ratings
  • 10 buy ratings
  • 11 hold ratings
  • 0 sell ratings
3/30/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 9 hold ratings
  • 0 sell ratings
6/28/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 8 hold ratings
  • 0 sell ratings
9/26/2020
  • 1 strong buy ratings
  • 11 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/25/2020
  • 1 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/25/2021
  • 1 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/24/2021
  • 1 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/23/2021

Latest Recommendations

  • 1 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/6/2021Morgan StanleyReiterated RatingOverweight ➝ Equal Weight$62.00Low
4/30/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$70.00 ➝ $62.00Low
4/13/2021Truist FinancialUpgradeHold ➝ BuyLow
4/13/2021Truist SecuritiesUpgradeHold ➝ Buy$66.00 ➝ $74.00Low
4/13/2021TruistUpgradeHold ➝ BuyLow
12/15/2020The Goldman Sachs GroupUpgradeBuy ➝ Conviction-BuyHigh
11/30/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target$73.00 ➝ $77.00Low
11/30/2020Smith Barney CitigroupBoost Price Target$73.00 ➝ $77.00Low
11/16/2020Societe GeneraleUpgradeHold ➝ Buy$76.00Low
11/10/2020Sanford C. BernsteinReiterated RatingMarket Perform$72.00Low
11/6/2020GabelliDowngradeBuy ➝ HoldLow
10/23/2020TruistInitiated CoverageHold$65.00Medium
10/19/2020GuggenheimUpgradeNeutral ➝ Buy$70.00Medium
10/16/2020JPMorgan Chase & Co.Boost Price TargetOverweight$74.00 ➝ $78.00Low
9/29/2020Berenberg BankInitiated CoverageBuy$73.00Low
9/25/2020Raymond JamesReiterated RatingBuyLow
9/22/2020Raymond JamesBoost Price TargetOutperform$75.00 ➝ $78.00Medium
8/12/2020Morgan StanleyBoost Price TargetOverweight$64.00 ➝ $66.00Low
7/28/2020Seaport Global SecuritiesInitiated CoverageOutperform$75.00 ➝ $75.00Low
7/28/2020Raymond JamesInitiated CoverageOutperform$75.00Medium
7/26/2020CfraReiterated RatingBuy$70.00Low
6/2/2020Cantor FitzgeraldBoost Price Target$68.00 ➝ $88.00Low
6/1/2020William BlairReiterated RatingBuyLow
5/15/2020Bank of AmericaReiterated RatingBuy$80.00Low
5/15/2020William BlairReiterated RatingBuyHigh
5/7/2020CfraBoost Price TargetBuy$69.00 ➝ $70.00Low
4/2/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$64.00Low
4/1/2020Bank of AmericaReiterated RatingBuy$75.00Low
3/23/2020Societe GeneraleDowngradeBuy ➝ Hold$50.00High
2/27/2020BarclaysInitiated CoverageEqual Weight$69.00High
2/14/2020William BlairReiterated RatingBuyLow
1/6/2020CitigroupUpgradeNeutral ➝ Buy$73.00Low
12/13/2019William BlairReiterated RatingBuyLow
12/13/2019ArgusUpgradeHold ➝ Buy$80.00Medium
11/27/2019GabelliInitiated CoverageBuyMedium
11/25/2019MizuhoInitiated CoverageBuyMedium
11/22/2019Morgan StanleyInitiated CoverageEqual Weight$60.00Low
11/18/2019William BlairReiterated RatingOutperformHigh
11/1/2019Wells Fargo & CompanySet Price TargetHold$110.00Low
11/1/2019SVB LeerinkSet Price TargetHold$115.00N/A
11/1/2019Wolfe ResearchSet Price TargetBuy$66.00N/A
11/1/2019Standpoint ResearchDowngradeBuy ➝ HoldLow
11/1/2019Robert W. BairdDowngradeOutperform ➝ Neutral$101.00Low
10/23/2019UBS GroupBoost Price TargetNeutral$51.00 ➝ $53.00Medium
10/20/2019MizuhoReiterated RatingHold$100.00Low
10/16/2019Bank of AmericaInitiated CoverageBuy$60.00Medium
10/10/2019Bank of AmericaBoost Price TargetNeutral$49.00 ➝ $50.00Low
9/13/2019JPMorgan Chase & Co.Set Price TargetBuy$62.00Low
9/3/2019Bank of AmericaBoost Price TargetNeutral$46.00 ➝ $49.00Low
8/19/2019MizuhoDowngradeBuy ➝ Neutral$103.00 ➝ $100.00Low
8/14/2019Atlantic SecuritiesUpgradeNeutral ➝ Overweight$63.00High
7/30/2019CowenReiterated RatingHold$102.00Low
7/3/2019MizuhoReiterated RatingBuy$103.00Low
6/25/2019MizuhoReiterated RatingBuy$103.00Low
6/13/2019UBS GroupLower Price TargetNeutral$55.00 ➝ $51.00Low
5/28/2019The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$54.00High
5/20/2019ArgusDowngradeBuy ➝ Hold$46.36Low
5/16/2019MizuhoReiterated RatingBuy$103.00Low
5/3/2019JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$62.00High
5/3/2019BarclaysDowngradeOverweight ➝ Equal Weight$102.00Medium
5/3/2019BarclaysUpgradeEqual Weight ➝ Overweight$53.00 ➝ $55.00High
4/17/2019BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$62.00 ➝ $63.00Low
4/5/2019MizuhoSet Price TargetBuy$103.00Low
4/5/2019Cantor FitzgeraldDowngradeOverweight ➝ Neutral$94.00Low
4/1/2019Sanford C. BernsteinDowngradeOutperform ➝ Market PerformLow
4/1/2019Atlantic SecuritiesDowngradeOverweight ➝ Neutral$94.34Low
4/1/2019UBS GroupDowngradeBuy ➝ Neutral$94.00 ➝ $102.00Low
4/1/2019William BlairDowngradeOutperform ➝ Market PerformLow
3/20/2019BMO Capital MarketsBoost Price TargetOutperform$62.00Medium
2/28/2019William BlairReiterated RatingBuyHigh
2/26/2019CowenInitiated CoverageMarket Perform$102.00Low
2/19/2019Bank of AmericaLower Price TargetNeutral ➝ Neutral$53.00 ➝ $51.00Low
2/19/2019BMO Capital MarketsReiterated RatingBuy$59.00Low
2/15/2019Credit Suisse GroupReiterated RatingHold$59.00Low
2/4/2019Credit Suisse GroupSet Price TargetHold$59.00High
2/1/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$95.00Low
1/31/2019Cantor FitzgeraldReiterated RatingBuy$100.00Medium
1/25/2019Bank of AmericaSet Price TargetHold$53.00Low
1/15/2019Societe GeneraleUpgradeSell ➝ BuyLow
1/4/2019Edward JonesDowngradeBuy ➝ HoldMedium
1/4/2019Robert W. BairdUpgradeNeutral ➝ Outperform$92.00High
1/3/2019The Goldman Sachs GroupUpgradeSell ➝ Neutral$71.00 ➝ $88.00High
1/3/2019Wells Fargo & CompanyLower Price TargetMarket Perform ➝ Market Perform$90.00 ➝ $84.00High
1/3/2019Canaccord GenuityDowngradeBuy ➝ HoldHigh
1/3/2019SVB LeerinkDowngradeOutperform ➝ Market PerformHigh
1/3/2019BMO Capital MarketsReiterated RatingBuy$60.00High
1/3/2019Cantor FitzgeraldReiterated RatingBuy$100.00High
12/20/2018Morgan StanleySet Price TargetHold$54.00Medium
12/20/2018BTIG ResearchInitiated CoverageNeutral ➝ NeutralHigh
12/19/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$93.00 ➝ $88.00Medium
12/17/2018CitigroupLower Price TargetNeutral ➝ Neutral$100.00 ➝ $77.00Low
12/13/2018Credit Suisse GroupReiterated RatingHold$59.00High
12/6/2018BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$60.00 ➝ $60.00High
11/27/2018BMO Capital MarketsLower Price TargetMarket Perform$56.00Medium
11/27/2018William BlairReiterated RatingOutperformMedium
11/16/2018BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$55.00 ➝ $58.00Low
11/14/2018Societe GeneraleSet Price TargetSell$47.00Low
11/6/2018Morgan StanleyLower Price TargetEqual Weight ➝ Hold$63.00 ➝ $59.00Low
10/30/2018MizuhoSet Price TargetBuy$117.00Medium
10/27/2018UBS GroupSet Price TargetBuy$94.00Medium
10/26/2018SVB LeerinkSet Price TargetHold$112.00Low
10/25/2018JPMorgan Chase & Co.Reiterated RatingBuyLow
10/23/2018BMO Capital MarketsLower Price TargetMarket Perform ➝ Market Perform$57.00 ➝ $54.00Medium
10/23/2018Wolfe ResearchInitiated CoverageOutperform$66.00Low
10/22/2018William BlairReiterated RatingOutperformHigh
10/22/2018CitigroupDowngradeBuy ➝ Neutral$62.00 ➝ $57.00High
10/14/2018Credit Suisse GroupSet Price TargetHold$61.00Low
10/12/2018BarclaysBoost Price TargetEqual Weight$55.00 ➝ $58.00Low
10/11/2018JPMorgan Chase & Co.Reiterated RatingBuyHigh
10/8/2018GuggenheimInitiated CoverageNeutral ➝ NeutralLow
10/8/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$70.00 ➝ $74.00Medium
10/1/2018Cantor FitzgeraldInitiated CoverageOverweight ➝ Overweight$100.00Low
9/12/2018Credit Suisse GroupReiterated RatingHold$61.00Low
8/8/2018Atlantic SecuritiesUpgradeUnderweight ➝ Neutral$57.00Medium
7/31/2018MizuhoReiterated RatingBuy$129.00Low
7/31/2018SunTrust BanksReiterated RatingBuy$67.00Low
7/27/2018SunTrust BanksReiterated RatingHold$101.00Low
7/27/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$91.00 ➝ $93.00N/A
7/27/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$58.00 ➝ $61.00N/A
7/23/2018BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$47.00 ➝ $51.00Medium
7/22/2018BMO Capital MarketsReiterated RatingHoldMedium
7/15/2018Jefferies Financial GroupSet Price TargetHold$58.00Low
7/13/2018Morgan StanleyBoost Price TargetEqual Weight$90.00 ➝ $91.00Low
7/10/2018CowenReiterated RatingBuy$150.00Low
7/10/2018MizuhoReiterated RatingBuy$118.00Low
6/21/2018BMO Capital MarketsReiterated RatingHold$47.00High
6/18/2018Standpoint ResearchUpgradeHold ➝ BuyLow
6/1/2018Cantor FitzgeraldSet Price TargetHold$112.00Low
5/30/2018Canaccord GenuityReiterated RatingBuyMedium
5/29/2018SunTrust BanksLower Price TargetHold$106.00 ➝ $96.00Low
5/24/2018Cantor FitzgeraldSet Price TargetHold$112.00Low
5/23/2018ArgusDowngradeBuy ➝ HoldLow
5/23/2018Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$102.00Low
5/21/2018UBS GroupDowngradeBuy ➝ Neutral$57.00Low
5/7/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$93.00 ➝ $90.00Low
5/7/2018SVB LeerinkReiterated RatingBuy$123.00 ➝ $115.00Medium
5/7/2018Royal Bank of CanadaDowngradeTop Pick ➝ Outperform$120.00High
5/6/2018BarclaysSet Price TargetBuy$107.00Medium
5/5/2018Cantor FitzgeraldSet Price TargetHold$112.00Medium
5/5/2018Credit Suisse GroupSet Price TargetBuy$129.00Medium
4/30/2018Evercore ISIReiterated RatingBuyLow
4/27/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$65.00 ➝ $55.00Low
4/27/2018BMO Capital MarketsUpgradeUnderperform ➝ Market PerformLow
4/26/2018Credit Suisse GroupSet Price TargetHold$58.00Low
4/26/2018BMO Capital MarketsReiterated RatingUnderperform ➝ Sell$47.00Low
4/20/2018CowenReiterated RatingHold$60.00Low
4/18/2018BMO Capital MarketsLower Price TargetUnderperform ➝ Underperform$51.00 ➝ $47.00Low
4/17/2018Credit Suisse GroupSet Price TargetBuy$129.00Low
4/17/2018Bank of AmericaLower Price TargetNeutral ➝ Neutral$68.00 ➝ $61.00Low
4/17/2018William BlairReiterated RatingOutperformHigh
4/17/2018Morgan StanleyDowngradeOverweight ➝ Equal Weight$54.08 ➝ $58.00High
4/13/2018Morgan StanleyReiterated RatingEqual ➝ Equal Weight$93.00Low
4/13/2018Jefferies Financial GroupReiterated RatingHold$66.00Low
4/2/2018Cantor FitzgeraldSet Price TargetHold$112.00Low
3/28/2018SVB LeerinkSet Price TargetBuy$123.00High
3/26/2018The Goldman Sachs GroupLower Price TargetSell ➝ Sell$97.00 ➝ $85.00Low
3/23/2018Jefferies Financial GroupSet Price TargetHold$70.00Medium
3/21/2018ArgusLower Price TargetBuy$75.00 ➝ $66.43Low
3/21/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$110.00Low
3/20/2018JPMorgan Chase & Co.Set Price TargetOverweight ➝ Overweight$70.00 ➝ $75.00Low
3/5/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$64.00 ➝ $68.00Medium
3/1/2018Robert W. BairdReiterated RatingHold$92.00Medium
3/1/2018Credit Suisse GroupSet Price TargetBuy$129.00Low
2/28/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$144.00 ➝ $139.00High
2/28/2018William BlairReiterated RatingBuyHigh
2/28/2018DZ BankDowngradeBuy ➝ HoldHigh
2/28/2018Credit Suisse GroupDowngradeBuy ➝ Hold$129.00 ➝ $90.00High
2/28/2018UBS GroupSet Price TargetBuy$106.00High
2/28/2018Stifel NicolausReiterated RatingBuy ➝ Buy$130.00 ➝ $128.00High
2/28/2018SunTrust BanksDowngradeBuy ➝ Hold$139.00 ➝ $106.00High
2/27/2018Cantor FitzgeraldSet Price TargetHold$112.00High
2/26/2018Jefferies Financial GroupSet Price TargetHold$72.00Low
2/16/2018CitigroupSet Price TargetBuy$78.00Low
2/15/2018Morgan StanleyUpgradeEqual Weight ➝ Overweight$51.56 ➝ $78.00High
2/14/2018BMO Capital MarketsSet Price TargetSell$51.00Low
2/13/2018BarclaysUpgradeEqual Weight ➝ Overweight$91.51 ➝ $105.00Low
2/6/2018BMO Capital MarketsLower Price TargetUnderperform ➝ Underperform$52.00 ➝ $51.00High
2/6/2018SVB LeerinkBoost Price TargetOutperform ➝ Positive$71.00 ➝ $76.00Medium
2/4/2018MizuhoReiterated RatingBuy$128.00High
1/29/2018Cantor FitzgeraldReiterated RatingHold$112.00Medium
1/26/2018SunTrust BanksReiterated RatingBuy$127.00 ➝ $139.00Low
1/24/2018BMO Capital MarketsReiterated RatingBuy$144.00Low
1/23/2018Royal Bank of CanadaReiterated RatingTop PickLow
1/23/2018BTIG ResearchReiterated RatingHoldMedium
1/23/2018Cantor FitzgeraldSet Price TargetHold$112.00Medium
1/22/2018Credit Suisse GroupSet Price TargetHold$62.00Low
1/22/2018BMO Capital MarketsReiterated RatingSell$52.00Low
1/18/2018Piper Jaffray CompaniesReiterated RatingHold$104.00Low
1/17/2018Cantor FitzgeraldSet Price TargetHold$112.00Medium
1/17/2018MizuhoSet Price TargetBuy$128.00High
1/10/2018GuggenheimReiterated RatingBuy$147.00Low
1/8/2018SunTrust BanksSet Price TargetBuy$127.00Medium
1/8/2018Credit Suisse GroupSet Price TargetBuy$125.00Medium
1/8/2018Stifel NicolausSet Price TargetBuy$130.00Medium
1/8/2018Deutsche Bank AktiengesellschaftSet Price TargetHold$110.00Low
1/8/2018OppenheimerSet Price TargetBuy$166.00High
1/8/2018Cantor FitzgeraldSet Price TargetHold$112.00High
1/5/2018MizuhoSet Price TargetBuy$128.00Low
1/5/2018Bank of AmericaDowngradeBuy ➝ Neutral$104.68 ➝ $120.00Medium
1/4/2018Royal Bank of CanadaReiterated RatingBuy$147.00High
12/31/2017SunTrust BanksSet Price TargetBuy$127.00Medium
12/30/2017Stifel NicolausLower Price TargetBuy$149.00 ➝ $130.00N/A
12/29/2017Cantor FitzgeraldSet Price TargetHold$112.00Low
12/28/2017OppenheimerSet Price TargetBuy$166.00Low
12/28/2017Credit Suisse GroupSet Price TargetBuy$123.00Low
12/27/2017Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$121.00High
12/26/2017MizuhoSet Price TargetBuy$128.00Low
12/25/2017GuggenheimSet Price TargetBuy$152.00Low
12/25/2017SunTrust BanksSet Price TargetBuy$127.00Low
12/22/2017SVB LeerinkReiterated RatingBuy$120.00Low
12/22/2017BMO Capital MarketsReiterated RatingBuy$147.00Low
12/22/2017CitigroupReiterated RatingHoldMedium
12/22/2017OppenheimerSet Price TargetBuy$166.00Low
12/22/2017Credit Suisse GroupSet Price TargetBuy ➝ Buy$128.00 ➝ $123.00High
12/22/2017Stifel NicolausLower Price TargetBuy ➝ Buy$149.00 ➝ $130.00High
12/21/2017Cantor FitzgeraldSet Price TargetHold$112.00High
12/14/2017OppenheimerSet Price TargetBuy$166.00Low
12/13/2017SVB LeerinkReiterated RatingBuy$120.00Low
12/12/2017Credit Suisse GroupSet Price TargetBuy$128.00Low
12/12/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold$114.00Low
12/11/2017BMO Capital MarketsSet Price TargetSell$49.00Low
12/11/2017Cantor FitzgeraldSet Price TargetHold$112.00High
12/10/2017Piper Jaffray CompaniesReiterated RatingHoldHigh
12/8/2017Atlantic SecuritiesUpgradeNeutral ➝ OverweightHigh
12/5/2017CitigroupSet Price TargetBuy$72.00Low
11/17/2017BMO Capital MarketsBoost Price TargetOutperform$148.00 ➝ $155.00N/A
11/16/2017Canaccord GenuitySet Price TargetBuy$140.00N/A
11/16/2017OppenheimerSet Price TargetBuy$166.00N/A
11/3/2017MizuhoReiterated RatingBuyN/A
10/30/2017OppenheimerReiterated RatingBuy$163.00 ➝ $166.00N/A
10/30/2017SunTrust BanksUpgradeHold ➝ BuyN/A
10/30/2017Cantor FitzgeraldReiterated RatingHold$112.00N/A
10/27/2017JPMorgan Chase & Co.Set Price TargetBuy$123.00N/A
10/27/2017UBS GroupLower Price TargetBuy$146.00 ➝ $120.00N/A
10/27/2017Canaccord GenuityReiterated RatingBuy$154.00 ➝ $140.00N/A
10/27/2017BMO Capital MarketsLower Price TargetOutperform$163.00 ➝ $148.00N/A
10/27/2017Credit Suisse GroupReiterated RatingHold$58.00 ➝ $61.00N/A
10/27/2017BarclaysReiterated RatingEqual Weight ➝ Equal Weight$135.00 ➝ $105.00N/A
10/27/2017CitigroupLower Price TargetNeutral$140.00 ➝ $102.00N/A
10/27/2017SunTrust BanksLower Price TargetBuy ➝ Buy$156.00 ➝ $127.00N/A
10/27/2017Royal Bank of CanadaLower Price TargetTop Pick$166.00 ➝ $148.00N/A
10/27/2017Cantor FitzgeraldDowngradeOverweight ➝ NeutralN/A
10/27/2017The Goldman Sachs GroupReiterated RatingSell$116.00 ➝ $91.00N/A
10/27/2017Morgan StanleyUpgradeUnderweight ➝ Equal WeightN/A
10/27/2017JMP SecuritiesDowngradeOutperform ➝ Market PerformN/A
10/27/2017Piper Jaffray CompaniesReiterated RatingHold$60.00N/A
10/27/2017Robert W. BairdReiterated RatingHold$103.00N/A
10/26/2017UBS GroupDowngradeStrong-Buy ➝ Market Perform$160.00N/A
10/26/2017Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformN/A
10/26/2017BMO Capital MarketsSet Price TargetSell$49.00N/A
10/26/2017Cantor FitzgeraldSet Price TargetBuy$162.00N/A
10/25/2017CitigroupSet Price TargetBuy$72.00N/A
10/23/2017GuggenheimInitiated CoverageBuy ➝ Buy$160.00N/A
10/23/2017SVB LeerinkBoost Price TargetOutperform$61.00 ➝ $72.00N/A
10/23/2017Morgan StanleyLower Price TargetUnderweight ➝ Underweight$120.00 ➝ $115.00N/A
10/23/2017Piper Jaffray CompaniesReiterated RatingNeutral ➝ Neutral$133.00N/A
10/22/2017BTIG ResearchReiterated RatingHoldN/A
10/20/2017SVB LeerinkReiterated RatingBuy$156.00N/A
10/20/2017OppenheimerReiterated RatingBuy$170.00N/A
10/20/2017Wells Fargo & CompanyReiterated RatingBuy$163.00N/A
10/20/2017BarclaysLower Price TargetEqual Weight$135.00 ➝ $105.00N/A
10/20/2017William BlairReiterated RatingOutperformN/A
10/20/2017UBS GroupLower Price TargetBuy ➝ Buy$153.00 ➝ $146.00N/A
10/20/2017Stifel NicolausLower Price TargetBuy$155.00 ➝ $149.00N/A
10/20/2017CitigroupDowngradeBuy ➝ NeutralN/A
10/20/2017Robert W. BairdDowngradeOutperform ➝ Neutral$162.00 ➝ $136.00N/A
10/18/2017CitigroupBoost Price TargetBuy$72.00N/A
10/17/2017Sanford C. BernsteinInitiated CoverageOutperform$162.00N/A
10/17/2017BMO Capital MarketsBoost Price TargetPositive$160.00 ➝ $167.00N/A
10/16/2017JPMorgan Chase & Co.Reiterated RatingBuyN/A
10/16/2017Jefferies Financial GroupReiterated RatingBuy$160.00N/A
10/16/2017Cantor FitzgeraldSet Price TargetBuy$162.00N/A
10/16/2017Jefferies Financial GroupDowngradeBuy ➝ Hold$72.00N/A
10/13/2017BarclaysBoost Price TargetEqual Weight$135.00 ➝ $140.00N/A
10/12/2017BMO Capital MarketsSet Price TargetSell$49.00N/A
10/6/2017UBS GroupReiterated RatingBuy$62.00 ➝ $72.00N/A
10/5/2017Royal Bank of CanadaReiterated RatingBuy$173.00N/A
10/5/2017Morgan StanleyDowngradeEqual Weight ➝ Underweight$120.00N/A
9/27/2017Jefferies Financial GroupReiterated RatingBuy$72.00Low
9/26/2017Cantor FitzgeraldReiterated RatingBuy$162.00Low
9/21/2017Robert W. BairdReiterated RatingBuy$162.00Low
9/19/2017CowenReiterated RatingHold$65.00Low
9/15/2017Jefferies Financial GroupReiterated RatingBuy$160.00Low
9/15/2017MizuhoBoost Price TargetBuy ➝ Buy$134.00 ➝ $158.00Medium
9/14/2017Royal Bank of CanadaInitiated CoverageTop Pick ➝ Top Pick$176.00High
9/13/2017Bank of AmericaReiterated RatingBuyLow
9/12/2017CowenReiterated RatingBuy$150.00Low
9/12/2017Hilliard LyonsDowngradeLong-term Buy ➝ Neutral$65.00Low
9/11/2017Jefferies Financial GroupBoost Price TargetBuy$66.00 ➝ $72.00Low
9/8/2017Credit Suisse GroupReiterated RatingNeutral ➝ HoldLow
9/7/2017The Goldman Sachs GroupReiterated RatingBuy$62.00 ➝ $65.00Low
9/5/2017BTIG ResearchReiterated RatingNeutralLow
9/4/2017BMO Capital MarketsReiterated RatingSell$49.00Low
8/28/2017Cantor FitzgeraldReiterated RatingBuyLow
8/24/2017Jefferies Financial GroupReiterated RatingBuy$63.00 ➝ $66.00Low
8/22/2017Cantor FitzgeraldReiterated RatingBuyLow
8/16/2017Credit Suisse GroupSet Price TargetHold$58.00Medium
8/14/2017CowenSet Price TargetHold$65.00Low
8/9/2017The Goldman Sachs GroupReiterated RatingBuy$63.00Medium
8/9/2017OppenheimerReiterated RatingOutperform$175.00Medium
7/31/2017Jefferies Financial GroupReiterated RatingBuy$160.00Low
7/31/2017OppenheimerReiterated RatingOutperform$148.00 ➝ $175.00Low
7/31/2017ArgusUpgradeHold ➝ Buy$96.93 ➝ $160.00Low
7/28/2017BarclaysReiterated RatingHold$135.00Low
7/28/2017BMO Capital MarketsReiterated RatingOutperform$152.00 ➝ $160.00Low
7/28/2017SVB LeerinkReiterated RatingOutperform$150.00 ➝ $160.00Low
7/28/2017SVB LeerinkLower Price TargetOutperform$66.00 ➝ $61.00Low
7/28/2017Stifel NicolausInitiated CoverageBuy$155.00Low
7/27/2017Canaccord GenuitySet Price TargetBuy$156.00Low
7/27/2017Piper Jaffray CompaniesSet Price TargetHold$60.00Medium
7/27/2017CowenReiterated RatingOutperform$150.00Low
7/27/2017Cantor FitzgeraldSet Price TargetBuy$160.00Medium
7/26/2017MizuhoSet Price TargetBuy$134.00High
7/26/2017BMO Capital MarketsReiterated RatingUnderperform$51.00 ➝ $47.00Low
7/21/2017Robert W. BairdReiterated RatingOutperform$162.00Low
7/17/2017Deutsche Bank AktiengesellschaftSet Price TargetHold$54.00 ➝ $55.00Low
7/14/2017SunTrust BanksReiterated RatingBuy$150.00Low
7/12/2017Jefferies Financial GroupReiterated RatingBuy$63.00Medium
7/11/2017Jefferies Financial GroupReiterated RatingBuy ➝ Buy$160.00Low
7/10/2017CowenSet Price TargetHold$65.00Low
7/10/2017Bank of AmericaReiterated RatingBuy$153.00Low
7/6/2017SunTrust BanksSet Price TargetBuy$150.00Low
7/6/2017Credit Suisse GroupSet Price TargetBuy$148.00Low
7/6/2017Stifel NicolausReiterated RatingBuy$139.00Low
7/6/2017Cantor FitzgeraldSet Price TargetBuy$160.00Low
6/30/2017BTIG ResearchDowngradeBuy ➝ Neutral$96.93 ➝ $131.70Low
6/26/2017William BlairReiterated RatingOutperformMedium
6/22/2017SVB LeerinkReiterated RatingOutperformLow
6/16/2017SVB LeerinkUpgradeMarket Perform ➝ Outperform$94.42 ➝ $150.00Medium
6/14/2017OppenheimerSet Price TargetBuy$148.00Low
6/8/2017OppenheimerSet Price TargetBuy$148.00Medium
6/6/2017Canaccord GenuitySet Price TargetBuy$156.00Low
6/5/2017Jefferies Financial GroupReiterated RatingBuy$64.00Medium
6/1/2017MizuhoBoost Price TargetBuy ➝ Buy$130.00 ➝ $134.00Medium
5/24/2017BTIG ResearchReiterated RatingBuy$138.00Low
5/24/2017JPMorgan Chase & Co.Reiterated RatingBuyLow
5/23/2017BMO Capital MarketsReiterated RatingOutperform$152.00Medium
5/22/2017Cantor FitzgeraldSet Price TargetBuy$160.00Low
5/22/2017Canaccord GenuitySet Price TargetBuy$156.00Low
5/22/2017Credit Suisse GroupSet Price TargetBuy$148.00Low
5/22/2017Robert W. BairdReiterated RatingOutperform$162.00Low
5/17/2017The Goldman Sachs GroupReiterated RatingSell$93.00 ➝ $98.00Low
5/13/2017Jefferies Financial GroupSet Price TargetBuy$154.00Low
5/5/2017ArgusDowngradeBuy ➝ Hold$123.91 ➝ $124.46Medium
5/3/2017BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$47.00Medium
5/1/2017BTIG ResearchReiterated RatingBuy$138.00Low
4/27/2017Cantor FitzgeraldSet Price TargetBuy$159.00Low
4/25/2017Robert W. BairdInitiated CoverageOutperformLow
4/23/2017BarclaysReiterated RatingEqual Weight$120.00 ➝ $125.00Low
4/23/2017BMO Capital MarketsReiterated RatingMarket Perform$45.00Low
4/19/2017Robert W. BairdReiterated RatingOutperform$162.00Low
4/11/2017Jefferies Financial GroupReiterated RatingBuy$154.00Low
4/5/2017OppenheimerReiterated RatingOutperform$148.00Low
4/4/2017BMO Capital MarketsReiterated RatingMarket Perform$45.00Low
3/20/2017SVB LeerinkReiterated RatingMarket PerformLow
3/11/2017Jefferies Financial GroupReiterated RatingBuy$64.00 ➝ $66.00N/A
3/9/2017UBS GroupInitiated CoverageBuy ➝ Buy$140.00N/A
3/8/2017Piper Jaffray CompaniesReiterated RatingNeutral$60.00Medium
3/8/2017CowenReiterated RatingOutperform$150.00Low
3/6/2017OppenheimerSet Price TargetBuy$148.00N/A
2/28/2017Jefferies Financial GroupBoost Price TargetBuy$147.00 ➝ $155.00N/A
2/25/2017OppenheimerSet Price TargetBuy$148.00N/A
2/25/2017Canaccord GenuitySet Price TargetBuy$156.00N/A
2/22/2017ArgusReiterated RatingBuy$75.00N/A
2/21/2017BMO Capital MarketsReiterated RatingMarket Perform$45.00N/A
2/19/2017MizuhoSet Price TargetBuy$130.00N/A
2/18/2017Cantor FitzgeraldSet Price TargetBuy$159.00N/A
2/18/2017Credit Suisse GroupSet Price TargetBuy$148.00N/A
2/18/2017JPMorgan Chase & Co.Reiterated RatingBuyN/A
2/17/2017OppenheimerSet Price TargetBuy$148.00N/A
2/17/2017Robert W. BairdReiterated RatingOutperform$162.00N/A
2/16/2017Canaccord GenuitySet Price TargetBuy$156.00N/A
2/16/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$42.00N/A
2/9/2017GabelliReiterated RatingBuyN/A
2/2/2017UBS GroupLower Price Target$64.00N/A
1/31/2017Jefferies Financial GroupReiterated RatingBuy$69.00 ➝ $66.00N/A
1/30/2017OppenheimerReiterated RatingOutperform$141.00 ➝ $148.00N/A
1/30/2017BTIG ResearchReiterated RatingBuy$138.00N/A
1/30/2017SVB LeerinkReiterated RatingOutperform$62.00N/A
1/27/2017Deutsche Bank AktiengesellschaftSet Price TargetHold$42.00N/A
1/27/2017Jefferies Financial GroupLower Price Target$60.00N/A
1/27/2017Jefferies Financial GroupBoost Price TargetBuy$142.00 ➝ $147.00N/A
1/27/2017BarclaysReiterated RatingEqual Weight$120.00N/A
1/27/2017The Goldman Sachs GroupLower Price TargetSell$96.00 ➝ $91.00N/A
1/27/2017Morgan StanleyLower Price TargetEqual Weight$120.00 ➝ $117.00N/A
1/26/2017Canaccord GenuitySet Price TargetBuy$156.00N/A
1/24/2017Cantor FitzgeraldReiterated RatingOverweight$159.00N/A
1/24/2017BarclaysLower Price TargetEqual Weight$65.00 ➝ $58.00N/A
1/23/2017BMO Capital MarketsBoost Price TargetMarket Perform$47.00 ➝ $53.00N/A
1/21/2017JPMorgan Chase & Co.Reiterated RatingBuyN/A
1/20/2017Jefferies Financial GroupReiterated RatingBuy$69.00N/A
1/20/2017CowenDowngradeOutperform ➝ Market Perform$77.12 ➝ $65.00N/A
1/20/2017William BlairReiterated RatingOurperformN/A
1/13/2017Cantor FitzgeraldSet Price TargetBuy$159.00N/A
1/12/2017CowenReiterated RatingOutperform$150.00N/A
1/11/2017Robert W. BairdReiterated RatingOutperform$162.00N/A
1/9/2017BMO Capital MarketsReiterated RatingBuy$144.00N/A
1/8/2017Evercore ISIReiterated RatingBuy$135.00N/A
1/6/2017Cantor FitzgeraldReiterated RatingBuy$159.00N/A
1/5/2017Jefferies Financial GroupReiterated RatingBuy$69.00N/A
12/20/2016OppenheimerSet Price TargetBuy$141.00N/A
12/20/2016Credit Suisse GroupReiterated RatingTop Pick ➝ Outperform$145.00N/A
12/19/2016Jefferies Financial GroupUpgradeHold ➝ Buy$69.00N/A
12/18/2016Jefferies Financial GroupReiterated RatingBuy$140.00N/A
12/6/2016MizuhoReiterated RatingBuy$130.00N/A
12/6/2016BMO Capital MarketsReiterated RatingOutperform$142.00N/A
12/5/2016Cantor FitzgeraldSet Price TargetBuy$159.00N/A
12/4/2016Royal Bank of CanadaReiterated RatingOutperformN/A
12/1/2016CowenSet Price TargetBuy$85.00N/A
11/30/2016Credit Suisse GroupSet Price TargetBuy$145.00N/A
11/30/2016Jefferies Financial GroupSet Price TargetBuy$140.00N/A
11/30/2016SVB LeerinkReiterated RatingMarket Perform$139.00N/A
11/29/2016OppenheimerInitiated CoverageOutperform$141.00N/A
11/29/2016UBS GroupInitiated CoverageOutperform$141.00 ➝ $120.30N/A
11/9/2016Standpoint ResearchDowngradeBuy ➝ HoldN/A
11/8/2016CitigroupReiterated RatingBuyN/A
11/7/2016MizuhoInitiated CoverageBuy$130.00N/A
10/31/2016Jefferies Financial GroupReiterated RatingHold$54.00 ➝ $58.00N/A
10/31/2016BTIG ResearchReiterated RatingBuy$138.00N/A
10/28/2016Cantor FitzgeraldReiterated RatingBuy$159.00N/A
10/28/2016Deutsche Bank AktiengesellschaftLower Price TargetHold$59.00 ➝ $52.00N/A
10/28/2016Hilliard LyonsUpgradeNeutral ➝ Buy$69.00N/A
10/27/2016Canaccord GenuitySet Price TargetBuy$156.00N/A
10/24/2016BMO Capital MarketsLower Price TargetMarket Perform$60.00 ➝ $56.00N/A
10/20/2016Stifel NicolausSet Price TargetBuy$138.00N/A
10/18/2016Piper Jaffray CompaniesReiterated RatingBuyN/A
10/18/2016Credit Suisse GroupReiterated RatingOutperform$140.00N/A
10/18/2016CowenReiterated RatingOutperform$150.00N/A
10/17/2016BMO Capital MarketsReiterated RatingOutperform$141.00N/A
10/17/2016Jefferies Financial GroupReiterated RatingBuy$134.00N/A
10/17/2016Credit Suisse GroupReiterated RatingHold$58.00N/A
10/15/2016Canaccord GenuitySet Price TargetBuy$156.00N/A
10/13/2016The Goldman Sachs GroupDowngradeStrong-Buy ➝ Buy$75.00N/A
10/12/2016BarclaysReiterated RatingEqual WeightN/A
10/10/2016SunTrust BanksReiterated RatingHold$68.00 ➝ $62.00N/A
10/9/2016SVB LeerinkReiterated RatingOutperform$69.00N/A
10/6/2016Jefferies Financial GroupReiterated RatingBuy$134.00N/A
10/3/2016BMO Capital MarketsReiterated RatingOutperform$141.00N/A
10/2/2016Piper Jaffray CompaniesReiterated RatingOverweight$145.00N/A
9/29/2016CitigroupBoost Price TargetBuy$124.00 ➝ $127.00N/A
9/27/2016The Goldman Sachs GroupReiterated RatingBuy$75.00N/A
9/20/2016CitigroupLower Price TargetBuy$75.00 ➝ $70.00N/A
9/18/2016Canaccord GenuitySet Price TargetBuy$156.00N/A
9/16/2016Bank of AmericaReiterated RatingBuy$128.00N/A
9/13/2016Robert W. BairdReiterated RatingOutperform$162.00N/A
9/13/2016BMO Capital MarketsReiterated RatingOutperform$141.00N/A
9/13/2016Jefferies Financial GroupReiterated RatingBuy$137.00N/A
9/12/2016Canaccord GenuitySet Price TargetBuy$156.00N/A
9/12/2016CowenReiterated RatingOutperform$150.00N/A
9/12/2016The Goldman Sachs GroupReiterated RatingBuyN/A
9/12/2016Piper Jaffray CompaniesReiterated RatingBuyN/A
9/12/2016SVB LeerinkReiterated RatingMarket Perform$135.00N/A
9/12/2016Morgan StanleyReiterated RatingEqual Weight$120.00N/A
9/12/2016Jefferies Financial GroupReiterated RatingHold ➝ Hold$69.00 ➝ $57.00N/A
9/9/2016BarclaysLower Price TargetEqual Weight$75.00 ➝ $65.00N/A
9/7/2016ArgusReiterated RatingBuy$155.00N/A
9/7/2016SVB LeerinkReiterated RatingBuy$75.00N/A
9/3/2016BMO Capital MarketsReiterated RatingMarket Perform$60.00N/A
8/31/2016Morgan StanleyReiterated RatingEqual Weight$120.00N/A
8/25/2016CowenReiterated RatingOutperform$150.00N/A
8/25/2016Morgan StanleyReiterated RatingNeutral ➝ HoldN/A
8/23/2016BMO Capital MarketsReiterated RatingOutperform$141.00N/A
8/23/2016Jefferies Financial GroupReiterated RatingBuyN/A
8/21/2016BTIG ResearchReiterated RatingBuy$138.00N/A
8/19/2016JPMorgan Chase & Co.Reiterated RatingOverweight$136.00N/A
8/19/2016UBS GroupLower Price TargetBuy$80.00 ➝ $70.00N/A
8/15/2016Piper Jaffray CompaniesSet Price TargetBuy$145.00N/A
8/15/2016Credit Suisse GroupReiterated RatingHold$63.00N/A
8/13/2016ArgusReiterated RatingBuy$90.00N/A
8/11/2016Berenberg BankDowngradeBuy ➝ Hold$80.00 ➝ $70.00N/A
8/11/2016Sanford C. BernsteinReiterated RatingMarket Perform$79.00 ➝ $65.00N/A
8/10/2016CowenReiterated RatingBuy$150.00N/A
8/10/2016William BlairReiterated RatingBuyN/A
8/9/2016Jefferies Financial GroupReiterated RatingBuy$137.00N/A
8/9/2016CitigroupLower Price TargetBuy$80.00 ➝ $75.00N/A
8/8/2016Piper Jaffray CompaniesReiterated RatingNeutral$69.00 ➝ $65.00N/A
8/8/2016Deutsche Bank AktiengesellschaftLower Price TargetHold$68.00 ➝ $62.00N/A
8/8/2016Jefferies Financial GroupLower Price TargetHold$80.00 ➝ $69.00N/A
8/7/2016Credit Suisse GroupDowngradeOutperform ➝ Neutral$86.00 ➝ $63.00N/A
8/5/2016Deutsche Bank AktiengesellschaftDowngradeHold ➝ SellN/A
8/5/2016Morgan StanleyDowngradeOverweight ➝ Equal Weight$63.00N/A
8/5/2016SunTrust BanksDowngradeBuy ➝ Neutral$86.00 ➝ $68.00N/A
8/3/2016BTIG ResearchUpgradeNeutral ➝ Buy$116.14 ➝ $138.00N/A
8/3/2016CitigroupLower Price TargetBuy$80.00 ➝ $75.00N/A
8/3/2016Morgan StanleyReiterated RatingHold$120.00N/A
8/2/2016Stifel NicolausReiterated RatingBuy$138.00N/A
8/1/2016SVB LeerinkReiterated RatingMarket Perform$125.00 ➝ $135.00N/A
7/29/2016UBS GroupReiterated RatingBuy$80.00N/A
7/29/2016SVB LeerinkReiterated RatingBuy$85.00N/A
7/28/2016Piper Jaffray CompaniesSet Price TargetBuy$145.00N/A
7/28/2016CowenReiterated RatingBuy$150.00N/A
7/26/2016Robert W. BairdReiterated RatingOutperform$162.00N/A
7/26/2016BMO Capital MarketsReiterated RatingBuy$141.00N/A
7/26/2016Royal Bank of CanadaReiterated RatingBuyN/A
7/26/2016Jefferies Financial GroupReiterated RatingBuy$138.00N/A
7/20/2016JPMorgan Chase & Co.Set Price TargetBuy$136.00N/A
7/17/2016Canaccord GenuityReiterated RatingOutperform$156.00N/A
7/14/2016Stifel NicolausInitiated CoverageBuy$138.00N/A
7/14/2016Jefferies Financial GroupBoost Price TargetHold$77.00 ➝ $80.00N/A
7/12/2016Berenberg BankReiterated RatingBuyN/A
7/12/2016Credit Suisse GroupReiterated RatingOutperform$140.00N/A
7/10/2016Jefferies Financial GroupReiterated RatingBuy$138.00N/A
7/6/2016The Goldman Sachs GroupReiterated RatingBuyN/A
7/6/2016JMP SecuritiesReiterated RatingBuy$152.00N/A
7/5/2016SVB LeerinkReiterated RatingHold$125.00N/A
7/5/2016Canaccord GenuityReiterated RatingBuy$156.00N/A
6/30/2016Morgan StanleyReiterated RatingHoldN/A
6/29/2016Jefferies Financial GroupReiterated RatingBuy$140.00N/A
6/27/2016Canaccord GenuityReiterated RatingBuy$156.00N/A
6/23/2016JMP SecuritiesReiterated RatingBuy$152.00N/A
(Data available from 6/23/2016 forward)
Bristol-Myers Squibb logo
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. The company offers products in hematology, oncology, cardiovascular, and immunology therapeutic classes. Its products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Opdivo for anti-cancer indications; Eliquis, an oral inhibitor indicated for the reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; and Orencia for adult patients with active RA and psoriatic arthritis, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis. The company also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a solvent-free protein-bound chemotherapy product; mpliciti for the treatment of multiple myeloma; and Reblozyl for the treatment of anemia in adult patients with beta thalassemia. In addition, it offers Onureg for the continued treatment of adult patients with AML; Zeposia to treat relapsing forms of multiple sclerosis; Vidaza for the treatment of myelodysplastic syndrome subtypes; Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B; and Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma. The company sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. It has collaboration agreements with Pfizer, Inc.; Otsuka Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.; Nektar Therapeutics; AVEO Pharmaceuticals, Inc.; Huyabio; and DarwinHealth, Inc. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.
Read More

Today's Range

Now: $65.26
Low: $65.24
High: $66.22

50 Day Range

MA: $65.55
Low: $62.42
High: $67.42

52 Week Range

Now: $65.26
Low: $56.67
High: $67.96

Volume

7,309,384 shs

Average Volume

11,591,248 shs

Market Capitalization

$145.72 billion

P/E Ratio

N/A

Dividend Yield

2.97%

Beta

0.64

Frequently Asked Questions

What sell-side analysts currently cover shares of Bristol-Myers Squibb?

The following Wall Street analysts have issued stock ratings on Bristol-Myers Squibb in the last twelve months: Berenberg Bank, Cfra, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Gabelli, Guggenheim, JPMorgan Chase & Co., Morgan Stanley, Raymond James, Sanford C. Bernstein, Seaport Global Securities, Smith Barney Citigroup, Societe Generale, The Goldman Sachs Group, Inc., TheStreet, Truist, Truist Financial Co., Truist Securities, and Zacks Investment Research.
View the latest analyst ratings for BMY.

What is the current price target for Bristol-Myers Squibb?

13 Wall Street analysts have set twelve-month price targets for Bristol-Myers Squibb in the last year. Their average twelve-month price target is $72.85, suggesting a possible upside of 10.5%. JPMorgan Chase & Co. has the highest price target set, predicting BMY will reach $78.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $62.00 for Bristol-Myers Squibb in the next year.
View the latest price targets for BMY.

What is the current consensus analyst rating for Bristol-Myers Squibb?

Bristol-Myers Squibb currently has 3 hold ratings, 10 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BMY will outperform the market and that investors should add to their positions of Bristol-Myers Squibb.
View the latest ratings for BMY.

What other companies compete with Bristol-Myers Squibb?

How do I contact Bristol-Myers Squibb's investor relations team?

Bristol-Myers Squibb's physical mailing address is 430 E. 29TH STREET 14 FLOOR, NEW YORK NY, 10016. The biopharmaceutical company's listed phone number is 212-546-4000 and its investor relations email address is [email protected] The official website for Bristol-Myers Squibb is www.bms.com.

Man who Picked Bitcoin at $428 Says "Buy Genesis"
He Picked Bitcoin (And Dogecoin) in 2016. What He's Recommending Now Could Turn Heads...